Captrust Financial Advisors Taro Pharmaceutical Industries LTD Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $603 - $704	-14 Reduced 19.44%	58 $3,000
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $47 - $65	-1 Reduced 1.37%	72 $4,000
Q3 2021 Nov 16, 2021	BUY	$62.34 - $73.38 $187 - $220	3 Added 4.29%	73 $5,000
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $210 - $229	-3 Reduced 4.11%	70 $5,000
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $5,145 - $5,836	73 New	73 $5,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.